MedTrace Logo

A Safety Study in Human Subjects Evaluating the Use of the Signati System for Vasectomy

NCT06402773 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2025-05-28

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and effectiveness of the Signati SeparoTM System when used in general surgical procedures where ligation and division of vessels are desired, such as the vas deferens. This study will evaluate the Signati SeparoTM System as a vasectomy device.

Conditions

  • Vasectomy

Interventions

DEVICE

The Signati Separo™ Vessel Sealing System

Vessel Sealing System

Sponsors & Collaborators

  • Signati Medical Inc

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-04-05
Primary Completion
2024-11-30
Completion
2024-12-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06402773 on ClinicalTrials.gov